Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency

This study has been completed.

Study NCT00161707 Information provided by Baxter Healthcare Corporation

First Received: September 8, 2005 Last Updated: October 18, 2006 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	October 2003
Estimated Primary Completion Date:	No date given